GNS Among Ways Amgen is Applying AI to Combat Serious Illness
Wired magazine dove in to a few approaches Amgen is taking to using AI to combat serious illness and one of those ways is by partnering with GNS! Amgen, the world’s largest independent biotech company, is leading the charge in combining life sciences with data...
Iya Khalil weighs in on AI in Real-World Drug Discovery
Following the recent Bio-IT conference, Iya Khalil and fellow keynote panelists weigh in on how AI is impacting real-world drug discovery efforts. Read the full article here.
GNS CEO Colin Hill joins rank of Top 50 Healthcare Technology CEOs of 2019
The Healthcare Technology Report evaluates the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. They gather data on each nominee’s professional background...
Adding Artificial Intelligence to Drug Discovery – Iya Khalil interviewed by GEN News
“AI is being used to really leverage learning from large-scale datasets, and those large-scale datasets are used to get to better novel targets.” – Iya Khalil, GNS Co-Founder and COO, joins Mike May of Genetic Engineering & Biotechnology News to...